Literature DB >> 7301710

Agonist potencies of tryptamine derivatives at pre- and postjunctional receptors in canine saphenous vein.

E Müller-Schweinitzer.   

Abstract

Strips form canine saphenous veins were incubated with (3H)-noradrenaline and mounted for superfusion. 5-Hydroxytryptamine (5-HT inhibited the release of tritium caused by sustained electrical stimulation (2 Hz, 150 mA, 0.1 msec) being about 10 times more potent than noradrenaline. 5-HT inhibited contractions induced by intermittent electrical stimulation at 2 Hz but increased the tone of the preparations in the absence of stimulation. Agonist potencies of tryptamine derivatives at prejunctional 5-HT receptors were determined by calculating those concentrations which would reduce the contractile effect of 2 Hz to that of 1 Hz, agonist potencies at postjunctional 5-HT receptors were determined by estimating the concentration which produces 50% of maximum response (pD2 values). Comparison of the agonist potencies at pre- and postjunctional receptors of various tryptamine derivatives suggest that in canine saphenous vein the two types of 5-HT receptor are structurally similar.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7301710

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  9 in total

1.  Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors.

Authors:  E Müller-Schweinitzer
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

2.  Actions of co-dergocrine mesylate and its components at vascular smooth muscle.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

3.  Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves.

Authors:  G Engel; M Göthert; E Müller-Schweinitzer; E Schlicker; L Sistonen; P A Stadler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

4.  Effects of 6-hydroxydopamine on pre- and post-junctional 5-HT1-like receptor-mediated responses in dog saphenous vein.

Authors:  A D Medhurst; G E Novotny; S G Parker; N M Deighton; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

5.  Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in the rat vena cava and in the heart of the pithed rat.

Authors:  M Göthert; E Schlicker; P Kollecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

6.  GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein.

Authors:  P P Humphrey; W Feniuk; M J Perren; H E Connor; A W Oxford; L H Coates; D Butina
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

7.  Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.

Authors:  P Leff; G R Martin; J M Morse
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

8.  Tissue specific susceptibility of alpha-adrenoceptor mediated vasoconstriction to nifedipine.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

9.  Inhibitory presynaptic 5-hydroxytryptamine (5-HT) receptors on the sympathetic nerves of the human saphenous vein.

Authors:  M Göthert; P Kollecker; N Rohm; H R Zerkowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.